De Prisco Michele, Oliva Vincenzo, Fico Giovanna, Kjærstad Hanne Lie, Miskowiak Kamilla Woznica, Anmella Gerard, Hidalgo-Mazzei Diego, Murru Andrea, Vieta Eduard, Radua Joaquim
Department of Medicine, Faculty of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), C. Casanova, 143, 08036 Barcelona, Catalonia, Spain; Bipolar and Depressive Disorders Unit, Hospìtal Clinic de Barcelona, c. Villarroel, 170, 08036 Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, 08036 Barcelona, Catalonia, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
Department of Medicine, Faculty of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), C. Casanova, 143, 08036 Barcelona, Catalonia, Spain; Bipolar and Depressive Disorders Unit, Hospìtal Clinic de Barcelona, c. Villarroel, 170, 08036 Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, 08036 Barcelona, Catalonia, Spain.
J Affect Disord. 2025 Sep 1;384:69-79. doi: 10.1016/j.jad.2025.04.159. Epub 2025 May 6.
Eye-tracking metrics, such as fixation latency, fixation count, saccade amplitude, and gaze duration, are emerging digital biomarkers that can enhance our understanding of cognitive and emotional alterations in mental disorders. For bipolar disorder (BD), eye-tracking offers a promising approach to investigate the mechanisms underlying the deficits in attention, inhibitory control, and emotion processing. This meta-analysis examined the differences in eye-tracking metrics in individuals with BD compared to healthy controls (HCs) or individuals with other psychiatric conditions, while observing images with emotional or non-emotional content. A comprehensive search of the PubMed/MEDLINE, Scopus, and PsycINFO databases was conducted from inception to August 20, 2024. Studies investigating differences in eye-tracking metrics using an image viewing paradigm were reviewed, and meta-analyses were performed. Ten studies met the inclusion criteria: BD (n = 337) was compared to HCs (n = 352) in all ten studies, to major depressive disorder (n = 60) in two studies, and to schizophrenia (n = 22) in one study. Meta-analyses were only feasible for comparisons between BD and HCs. Individuals with BD exhibited higher latency for the first fixation, a reduced number of fixations, shorter gaze duration, and lower saccadic peak velocity and amplitude. Additionally, they showed shorter fixation durations only when viewing images with negative content. This report provides valuable insights into the cognitive and emotional difficulties faced by individuals with BD, which can guide the development of more targeted and effective assessments and interventions for this population.
眼动追踪指标,如注视潜伏期、注视次数、扫视幅度和注视持续时间,正成为数字生物标志物,能够增进我们对精神障碍中认知和情绪变化的理解。对于双相情感障碍(BD)而言,眼动追踪为研究注意力、抑制控制和情绪加工缺陷背后的机制提供了一种很有前景的方法。这项荟萃分析研究了BD患者与健康对照者(HCs)或患有其他精神疾病的个体在观察带有情感或非情感内容的图像时,眼动追踪指标的差异。对PubMed/MEDLINE、Scopus和PsycINFO数据库从创建到2024年8月20日进行了全面检索。对使用图像观看范式研究眼动追踪指标差异的研究进行了综述,并开展了荟萃分析。十项研究符合纳入标准:在所有十项研究中,BD患者(n = 337)与HCs(n = 352)进行了比较,在两项研究中与重度抑郁症患者(n = 60)进行了比较,在一项研究中与精神分裂症患者(n = 22)进行了比较。荟萃分析仅适用于BD与HCs之间的比较。BD患者首次注视的潜伏期更长,注视次数减少,注视持续时间更短,扫视峰值速度和幅度更低。此外,他们仅在观看带有负面内容的图像时表现出更短的注视持续时间。本报告为BD患者面临的认知和情绪困难提供了有价值的见解,可为针对该人群开发更具针对性和有效性的评估及干预措施提供指导。